SCHEMBL29587402

SCHEMBL29587402

C=CC(=O)N[C@@H](CCS)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.42
FOLH1 Q04609 3/20 0.41
RIMKLA Q8IXN7 1/20 0.38
NAALAD2 Q9Y3Q0 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38
ALOX15 P16050 1/20 0.38
NFKB1 P19838 1/20 0.38
PTGS2 P35354 1/20 0.38
THPO P40225 1/20 0.38
RECQL P46063 1/20 0.38
BLM P54132 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TGM2 P21980 7/20 0.38
ALDH1A1 P00352 1/20 0.35
MAPK1 P28482 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ACE P12821 1/20 0.35
GNPAT O15228 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4305909 0.84 KDM4E (0.55) TSHRFOLH1KDM4EMAPTTHRB
SCHEMBL3054458 0.84 KDM4E (0.55) TSHRFOLH1KDM4EMAPTTHRB
SCHEMBL9382037 0.81 FOLH1 (0.62) FOLH1RIMKLANAALAD2GNPATFNTA
SCHEMBL5437088 0.81 FOLH1 (0.62) FOLH1RIMKLANAALAD2GNPATFNTA
SCHEMBL5437090 0.81 FOLH1 (0.62) FOLH1RIMKLANAALAD2GNPATFNTA
SCHEMBL28421 0.81 TSHR (0.47) TSHRFOLH1RIMKLANAALAD2TGM2
SCHEMBL8185037 0.81 TSHR (0.47) TSHRFOLH1RIMKLANAALAD2TGM2
SCHEMBL15361783 0.79 FOLH1 (0.60) FOLH1RIMKLANAALAD2GNPATFNTA
SCHEMBL32667918 0.78 TSHR (0.43) TSHRFOLH1RIMKLANAALAD2KDM4E
SCHEMBL8185224 0.78 KMT2A (0.47) TSHRFOLH1RIMKLANAALAD2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12214086-B2 Surface functionalized, host-guest polymer nano-assemblies and methods thereof UNIVERSITY OF MASSACHUSETTS (US) 2025-02-04 US disclosed
EP-4240579-B1 METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES ALCON INC (CH) 2024-12-04 EP disclosed
US-11975499-B2 Method for making photochromic contact lenses ALCON INC. (CH) 2024-05-07 US disclosed
EP-4240579-A1 METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES Alcon Inc. (CH) 2023-09-13 EP disclosed
WO-2022097049-A1 METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES ALCON INC. (CH) 2022-05-12 WO disclosed
US-20220134692-A1 METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES ALCON INC. (CH) 2022-05-05 US disclosed
US-20220133639-A1 SURFACE FUNCTIONALIZED, HOST-GUEST POLYMER NANO-ASSEMBLIES AND METHODS THEREOF UNIV MASSACHUSETTS (US) 2022-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220133639-A1 SURFACE FUNCTIONALIZED, HOST-GUEST POLYMER NANO-ASSEMBLIES AND METHODS THEREOF MSN, CD44, EPHA2 TSHR 2840/4885FOLH1 552/4885RIMKLA 1703/4885
US-12214086-B2 Surface functionalized, host-guest polymer nano-assemblies and methods thereof MSN, CD44, EPHA2 TSHR 2840/4885FOLH1 552/4885RIMKLA 1703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.